Le Lézard
Classified in: Health, Business
Subject: TNM

Kansas City Dermatology Joins Epiphany Dermatology


AUSTIN, Texas, Nov. 12, 2019 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its national presence into Kansas through its partnership with Kansas City Dermatology. 

(PRNewsfoto/CI Capital Partners)

Founded in 1987 by Mark McCune, MD, Kansas City Dermatology has a long-established reputation of providing high-quality dermatology services to patients in the greater Kansas City market.  Dr. McCune is a board-certified dermatologist who earned his medical degree at the University of Kansas School of Medicine and completed his dermatology residency at Mayo Graduate School of Medicine. 

Dr. McCune commented, "My staff and I are excited to join Epiphany, which has proven itself to be a high-quality company comprised of caring dermatologists.  Epiphany shares the values and goals that my staff and I believe in ? providing excellent care across the entire spectrum of medical, surgical, and cosmetic dermatologic needs. By forming this partnership with Epiphany, we will expand our ability to treat skin conditions and cancers in our community.  Epiphany has the infrastructure to help us manage the growing regulatory burdens that have the potential to interfere with our ability to focus on what matters most ? taking care of our patients and serving our community."   

Gheorghe Pusta, Co-Founder and Chief Executive Officer of Epiphany, said, "We are pleased to welcome Dr. McCune and his staff to Epiphany.  Through our interactions with Dr. McCune, we were impressed with his commitment to clinical excellence across a variety of service lines, including a robust clinical research program.  He and his team are dedicated to improving access to care in the greater Kansas City market.  This is a nice opportunity for Epiphany to expand our provider network and improve access to exceptional dermatologic care in Kansas."

Through this partnership, Kansas City Dermatology's providers and staff gain additional resources to help with operations, managed care, marketing, compliance, human resources, recruiting, IT, and many other support services. 

About Epiphany Dermatology

Epiphany Dermatology is a rapidly expanding dermatology company, driven by a passion to improve access to exceptional dermatologic care in a values-based manner. Through its partnership with leading dermatologists across 48 locations in Arizona, Colorado, Iowa, Kansas, Minnesota, Missouri, New Mexico, Oklahoma, and Texas, Epiphany provides general dermatology, skin cancer care, Mohs surgery, cosmetic services, and additional dermatologic services.  Epiphany raises the standard of dermatology care by making clinical excellence accessible to all patients, promptly and in a warm and inviting environment.  Epiphany Dermatology is headquartered in Austin, Texas.  For more details, please visit www.epiphanydermatology.com or call (512) 628-0465.

Ted Emmert
Chief Development Officer
Epiphany Dermatology 
(512) 628-0465
[email protected]

Gheorghe Pusta
Chief Executive Officer
Epiphany Dermatology
(512) 628-0465
[email protected]

SOURCE CI Capital Partners


These press releases may also interest you

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

at 09:00
Arbele, a clinical-stage biotechnology company focused...

at 08:53
Alera Health, a leader in population health management integrating behavioral healthcare, is proud to announce its recognition as one of the Great Employers to Work for in North Carolina by Best Companies Group. The 2024 Great Employers to Work for...



News published on and distributed by: